IMI

An analysis of journal papers indicates IMI’s research has a high impact, but the partnership’s former head Michel Goldman says bibliometrics do not properly reflect the interests of participants. New metrics are needed to assess interdisciplinary projects

The current head of Genome Canada will take over as executive director of the world’s largest pharmaceuticals public-private partnership in September

The €2 million Innovative Medicines initiative, set up to restore the competitive position of Europe’s pharma sector, has entered its second phase.